Skip to main content
Log in

Clinical relationships between the rs2212020 and rs189897 polymorphisms of the ITGA9 gene and epithelial ovarian cancer

  • Research Article
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

To better understand the role of integrin subunit alpha 9 (ITGA9) gene polymorphism in epithelial ovarian cancer (EOC), we investigated the distribution of ITGA9 gene polymorphisms (rs2212020 and rs189897) and revealed whether these polymorphisms were associated with a curative effect in EOC. It was found that rs2212020 and rs189897 were correlated significantly with EOC incidence. The frequency of the C allele of rs2212020 was significantly higher in EOC patients than in the control group (\(P=0.009\), \(\upchi ^{2}=6.857\)). The population with the C allele of rs2212020 had a higher EOC risk than the population with the T allele (\(\hbox {hazard ratio}=1.97\), 95.0% \(\hbox {CI} =1.178-3.299\)). Further, our results showed that the CC genotype was a risk factor for EOC. Regarding the association between ITGA9 and the sensitivity to platinum-based chemotherapy in EOC, there were no statistically significant differences in the frequencies of the rs189897 and rs2212020 polymorphisms between the chemosensitive group and the control group. In multivariate analysis, the patients with the TT genotype of rs189897 had longer progression-free survival (PFS) than the patients without this genotype (\(P=0.010\), \(\hbox {OR}=2.491\)). The AT genotype of rs189897 was a risk factor for PFS in EOC. These findings suggested that rs189897 and rs2212020 could play important roles in EOC diagnosis and prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Barrett J. C., Fry B., Maller J. and Daly M. J. 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265.

    Article  CAS  Google Scholar 

  • Covens A., Carey M., Bryson P., Verma S., Fung Kee Fung M. and Johnston M. 2002 Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer. Gynecol. Oncol. 85, 71–80.

    Article  CAS  Google Scholar 

  • Cuneo M. G., Schrepf A., Slavich G. M., Thaker P. H., Goodheart M., Bender D. et al. 2017 Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer. Psychoneuroendocrinology 84, 139–142.

    Article  CAS  Google Scholar 

  • Dmitriev A. A., Kashuba V. I., Haraldson K., Senchenko V. N., Pavlova T. V., Kudryavtseva A. V. et al. 2012 Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics 7, 502–513.

    Article  CAS  Google Scholar 

  • Dmitriev A. A., Rosenberg E. E., Krasnov G. S., Gerashchenko G. V., Gordiyuk V. V., Pavlova T. V. et al. 2015 Identification of novel epigenetic markers of prostate cancer by NotI-microarray analysis. Dis. Markers 2015, 241301.

    Article  Google Scholar 

  • Dong X., Men X., Zhang W. and Lei P. 2014 Advances in tumor markers of ovarian cancer for early diagnosis. Indian J. Cancer 51, e72–e76.

    Article  Google Scholar 

  • Gerashchenko G. V., Gordiyuk V. V., Skrypkina I. Y., Kvasha S. M., Kolesnik O. O., Ugryn D. D. et al. 2009 Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer. Ukr. Biokhim. Zh. 81, 81–87.

    CAS  Google Scholar 

  • Guichet P. O., Guelfi S., Teigell M., Hoppe L., Bakalara N., Bauchet L. et al. 2015 Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells. Stem Cells 33, 21–34.

    Article  CAS  Google Scholar 

  • Guo W. and Giancotti F. G. 2004 Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816–826.

    Article  CAS  Google Scholar 

  • Jessmon P., Boulanger T., Zhou W. and Patwardhan P. 2017 Epidemiology and treatment patterns of epithelial ovarian cancer. Expert Rev. Anticancer Ther. 17, 427–437.

    Article  CAS  Google Scholar 

  • Junzo K. 2013 New strategy for overcoming resistance to chemotherapy of ovarian cancer. Yonago Acta Med. 56, 43–50.

    Google Scholar 

  • Kashuba V., Dmitriev A. A., Krasnov G. S., Pavlova T., Ignatjev I., Gordiyuk V. V. et al. 2012 NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer. Int. J. Mol. Sci. 13, 13352–13377.

    Article  CAS  Google Scholar 

  • Li X. M., Li J., Zeng F. and Yi H. 2011 Association of ITGA9 gene rs189897 and rs2212020 genotypes and its haplotype with cerebral infarction (article in Chinese). Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 31, 1142–1145.

  • Lo K. W., Teo P. M., Hui A. B., To K. F., Tsang Y. S., Chan S. Y. et al. 2000 High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res. 60, 3348–3353.

    CAS  PubMed  Google Scholar 

  • May T., Comeau R., Sun P., Kotsopoulos J., Narod S. A., Rosen B. et al. 2017 A comparison of survival outcomes in advanced serous ovarian cancer patients treated with primary debulking surgery versus neoadjuvant chemotherapy. Int. J. Gynecol. Cancer 27, 668–674.

    Article  Google Scholar 

  • Mostovich L. A., Prudnikova T. Y., Kondratov A. G., Loginova D., Vavilov P. V., Rykova V. I. et al. 2011 Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. Cell Adh Migr. 5, 395–401.

    Article  Google Scholar 

  • Nawaz I., Hu L. F., Du Z. M., Moumad K., Ignatyev I., Pavlova T. V. et al. 2015 Integrin \(\upalpha \)9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma. Oncotarget 6, 31493–31507.

  • Ng C. C., Yew P. Y., Puah S. M., Krishnan G., Yap L. F., Teo S. H. et al. 2009 A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J. Hum. Genet. 54, 392–397.

    Article  CAS  Google Scholar 

  • Ortega P., Moran A., Fernandez-Marcelo T., De Juan C., Frias C., Lopez-Asenjo J. A. et al. 2010 MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway. Int. J. Oncol. 36, 1209–1215.

    CAS  PubMed  Google Scholar 

  • Park H. K., Ruterbusch J. J. and Cote M. L. 2017 Recent trends in ovarian cancer incidence and relative survival in the U.S. by race/ethnicity and histologic subtypes. Cancer Epidemiol. Biomarkers Prev. 26, 1511–1518.

    Article  Google Scholar 

  • Pastuszak-Lewandoska D., Kordiak J., Antczak A., Migdalska-Sęk M., Czarnecka K. H., Górski P. et al. 2016 Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer. Med. Oncol. 33, 75.

    Article  Google Scholar 

  • Pavlova T. V., Kashuba V. I., Muravenko O. V., Yenamandra S. P., Ivanova T. A., Zabarovskaia V. I. et al. 2009 Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome. Mol. Biol. (Mosk). 43, 339–347.

    Article  CAS  Google Scholar 

  • Senchenko V. N., Kisseljova N. P., Ivanova T. A., Dmitriev A. A., Krasnov G. S., Kudryavtseva A. V. et al. 2013 Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer. Epigenetics 8, 409–420.

    Article  CAS  Google Scholar 

  • Sherry S. T., Ward M. H., Kholodov M., Baker J., Phan L., Smigielski E. M. and Sirotkin K. 2001 dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311.

    Article  CAS  Google Scholar 

  • Shi Y. Y. and He L. 2005 SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15, 97–98.

    Article  CAS  Google Scholar 

  • Takada Y., Ye X. and Simon S. 2007 The integrins. Genome Biol. 8, 1–9.

    Article  Google Scholar 

  • Torre L. A., Bray F., Siegel R. L., Ferlay J., Lortet-Tieulent J. and Jemal A. 2011 Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87–108.

    Article  Google Scholar 

  • Vozianov S. O., Kashuba V. I., Grygorenko V. M., Gordiyuk V. V., Danylets R. O., Bondarenko Y. M. et al. 2016 Identification of a new diagnostic marker of prostatic cancer, using NotI-microchips [article in Ukrainian]. Klin Khir. 4, 54–57.

    Google Scholar 

  • Xiong W., Zeng Z. Y., Xia J. H., Xia K., Shen S. R., Li X. L. et al. 2004 A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 64, 1972–1974.

    Article  CAS  Google Scholar 

  • Zagouri F., Dimopoulos M. A., Bournakis E. and Papadimitriou C. A. 2010 Molecular markers in epithelial ovarian cancer: their role in prognosis and therapy. Eur. J. Gynaecol. Oncol. 31, 268–277.

    CAS  PubMed  Google Scholar 

  • Zhang J., Na S., Liu C., Pan S., Cai J. and Qiu J. 2016 MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma. Tumour Biol. 37, 5941–5949.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by National Natural Sciences Foundation of China (81672685, 81272975); the Key Planned Science and Technology Project of Hunan Province (2012FJ3084); the Planned Project of Department of Health of Hunan Province (B2011-030, B2012-029); the Natural Science Foundation of Xinjiang Autonomous Region (2017D01C122).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yanhong Zhou or Keqiang Zhang.

Additional information

Corresponding editor: H. A. Ranganath

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Liu, T., Liang, L. et al. Clinical relationships between the rs2212020 and rs189897 polymorphisms of the ITGA9 gene and epithelial ovarian cancer. J Genet 98, 28 (2019). https://doi.org/10.1007/s12041-019-1078-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12041-019-1078-1

Keywords

Navigation